The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism

by Alice Bessey, James Chilcott, Abdullah Pandor, Suzy Paisley
Published 2020-11-01

Economic impact of screening for X-linked Adrenoleukodystrophy within a newborn blood spot screening programme

by Alice Bessey, James B Chilcott, Joanna Leaviss, Anthea Sutton
Published 2018-10-01

A Cost-Effectiveness Analysis of Newborn Screening for Severe Combined Immunodeficiency in the UK

by Alice Bessey, James Chilcott, Joanna Leaviss, Carmen de la Cruz, Ruth Wong
Published 2019-08-01

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis

by Sue Harnan, Paul Tappenden, Katy Cooper, John Stevens, Alice Bessey, Rachid Rafia, Sue Ward, Ruth Wong, Robert C Stein, Janet Brown
Published 2019-06-01

A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptab...

by C Jane Morrell, Paul Sutcliffe, Andrew Booth, John Stevens, Alison Scope, Matt Stevenson, Rebecca Harvey, Alice Bessey, Anna Cantrell, Cindy-Lee Dennis, Shijie Ren, Margherita Ragonesi, Michael Barkham, Dick Churchill, Carol Henshaw, Jo Newstead, Pauline Slade, Helen Spiby, Sarah Stewart-Brown
Published 2016-05-01